[Treatment of bacterial meningitis in Norway].
Infections with Group B meningococci have been a dominant infection problem in Norway in the last 15 years. The Norwegian recommendations as to treatment are reported in the article.
Brandtzaeg
P
P
Avd for bakteriologi, Statens Institutt for folkehelse, Oslo.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002444:Cefuroxime / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008583:Meningitis, Haemophilus / Q000188:drug therapy* / Q000453:epidemiology; D009664:Norway / Q000453:epidemiology; D010400:Penicillin G / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D000667:Ampicillin; D002444:Cefuroxime; D010400:Penicillin G
Behandling av bakteriell meningitt i Norge.